ExLibris header image
SFX Logo
Title: Pathway-based analysis of GWAs data identifies association of sex determination genes with susceptibility to testicular germ cell tumors
Source:

Human Molecular Genetics [0964-6906] Koster, Roelof yr:2014


Collapse list of basic services Basic
Sorry, no full text available...
Please use the document delivery service (see below)  
Holding information
Holdings in library search engine ALBERT GO
Document delivery
Request document via Library/Bibliothek GO
Users interested in this article also expressed an interest in the following:
1. Litchfield, K. "Multi-stage genome-wide association study identifies new susceptibility locus for testicular germ cell tumour on chromosome 3q25." Human molecular genetics 24.4 (2014): 1169-76. Link to SFX for this item
2. Kratz, Christian P. "Variants in or near KITLG, BAK1, DMRT1, and TERT-CLPTM1L predispose to familial testicular germ cell tumour." Journal of medical genetics (2011): 473-476. Link to SFX for this item
3. Litchfield, K. "Common variants identified in genome-wide association studies of testicular germ cell tumour: an update, biological insights and clinical application." Andrology 3.1 (2015): 34-46. Link to Full Text for this item Link to SFX for this item
4. von der Emde, L. "Prostaglandin receptors EP1-4 as a potential marker for clinical outcome in urothelial bladder cancer." American journal of cancer research 4.6 (2014): 952-62. Link to Full Text for this item Link to SFX for this item
5. Rahman, N. "Mainstreaming genetic testing of cancer predisposition genes." Clinical medicine 14.4 (2014): 436-9. Link to Full Text for this item Link to SFX for this item
6. Zeron Medina, J. "A Polymorphic p53 Response Element in KIT Ligand Influences Cancer Risk and Has Undergone Natural Selection." Cell 155.2 (2013): 410-22. Link to SFX for this item
7. Lessel, D. "Replication of genetic susceptibility loci for testicular germ cell cancer in the Croatian population." Carcinogenesis 33.8 (2012): 1548-1552. Link to SFX for this item
8. Bunnell, Joanne E. "The Clinical Utility of Next Generation Sequencing Results in a Community-Based Hereditary Cancer Risk Program." Journal of Genetic Counseling 26.1 (2017): 105-112. Link to SFX for this item
9. Summersgill, K. "Whole-exome sequencing reveals the mutational spectrum of testicular germ cell tumours." Nature communications 6 (2015): 5973-. Link to Full Text for this item Link to SFX for this item
10. Rahman, N. "Germline mutations in the PAF1 complex gene CTR9 predispose to Wilms tumour." Nature communications 5 (2014): 4398-. Link to Full Text for this item Link to SFX for this item
11. Pitcher, Oliver J. "Observational study of regional aortic size referenced to body size: production of a cardiovascular magnetic resonance nomogram." Journal of cardiovascular magnetic resonance 16.1 (2014): 1-18. Link to Full Text for this item Link to SFX for this item
12. Lerner, Ethan A. "The Missing Link between Itch and Inflammation in Atopic Dermatitis." Cell 155.2 (2013): 267-269. Link to SFX for this item
13. Kollmannsberger, C. "Active Surveillance Is the Preferred Approach to Clinical Stage I Testicular Cancer." Journal of clinical oncology 31.28 (2013): 3490-3493. Link to SFX for this item
14. Paz, Edwin A. "Polyamines are oncometabolites that regulate the LIN28/let-7 pathway in colorectal cancer cells." Molecular carcinogenesis 53.S1 (2013): 96-106. Link to Full Text for this item Link to SFX for this item
15. Kratz, C P. "A stratified genetic risk assessment for testicular cancer." International journal of andrology 34.4pt2 (2011): -102. Link to Full Text for this item Link to SFX for this item
16. Davies, P. "Implications of quantum metabolism and natural selection for the origin of cancer cells and tumor progression." AIP Advances 2.1 (2012): 11101-11101. Link to SFX for this item
17. Belge, G. "Serum levels of microRNAs miR-371-3: a novel class of serum biomarkers for testicular germ cell tumors?" European urology 61.5 (2012): 1068-1069. Link to SFX for this item
18. Yuen, John S P S. "Targeting the type 1 insulin-like growth factor receptor as a treatment for cancer." Expert Opinion on Therapeutic Targets 12.5 (2008): 589-603. Link to SFX for this item
View More...
View Less...
Select All Clear All

Expand list of advanced services Advanced